GeneDx Holdings Corp. (WGS)

GeneDx Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,562	2,111	71	102	1,076	20,163
Market Cap Growth	945.06%	2866.28%	-30.24%	-90.52%	-94.66%	-
Enterprise Value	2,518	2,111	31	-11	648	20,051
Last Close Price	89.79	76.86	2.75	8.71	147.18	364.32
Forward PE	73.25	190.96	-	-	-	-
PS Ratio	7.46	6.91	0.35	0.44	5.07	112.44
PB Ratio	9.95	8.61	0.31	0.40	2.77	4595.00
P/TBV Ratio	25.04	24.37	1.29	1.52	2.77	-
EV/Sales Ratio	7.63	6.91	0.15	-	3.06	111.81
Debt / Equity Ratio	0.45	0.47	0.52	0.30	0.03	10.26
Debt / EBITDA Ratio	7.11	17.38	-	-	-	-
Asset Turnover	0.79	0.73	0.45	0.45	0.53	0.79
Inventory Turnover	9.45	11.43	10.34	11.02	7.83	7.61
Quick Ratio	2.95	3.26	2.77	1.17	4.22	1.91
Current Ratio	3.25	3.61	3.10	1.47	4.77	2.37
Return on Equity (ROE)	-16.61%	-22.10%	-72.97%	-171.07%	-125.04%	-363.49%
Return on Assets (ROA)	-1.84%	-3.20%	-22.72%	-54.49%	-69.21%	-61.04%
Return on Capital (ROIC)	-2.22%	-3.79%	-30.48%	-78.02%	-124.34%	-137.09%
Earnings Yield	-1.51%	-2.48%	-246.93%	-538.02%	-22.80%	-1.20%
FCF Yield	-0.51%	-1.61%	-260.46%	-319.80%	-18.57%	-0.58%
Buyback Yield / Dilution	-6.20%	-10.61%	-137.49%	-212.57%	-	-

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q